Literature DB >> 3032718

Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice.

C J Bailey, P R Flatt.   

Abstract

Plasma glucose and insulin responses to opiate receptor stimulation and antagonism were determined in 12-14 week old lean and obese-diabetic Aston ob/ob mice. The opiate receptor antagonist naloxone (1 mg/kg intraperitoneally) rapidly and transiently raised glucose and suppressed insulin concentrations in lean mice, and produced qualitatively similar but more protracted response in ob/ob mice. Selective stimulation of mu- and delta-opiate receptors using the enkephalin analogues Tyr-D-Ala-Gly-MePhe-NH(CH2)2OH (1 mg/kg, intraperitoneally) and Tyr-D-Ala-Gly-Phe-D-Leu (10 mg/kg intraperitoneally) respectively, rapidly and transiently increased glucose and insulin concentrations in lean and ob/ob mice. The ob/ob mice exhibited greater glucose and insulin responses to these analogues. The results provide evidence that endogenous opiates participate in the regulation of glucose and insulin homeostasis, and suggest that increased responsiveness to mu- and delta-opiate receptor stimulation may contribute to the hyperglycaemia and hyperinsulinaemia of obese-diabetic mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032718     DOI: 10.1007/BF01788904

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  40 in total

1.  C-fragment of lipotropin--an endogenous potent analgesic peptide.

Authors:  W Feldberg; D G Smyth
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

2.  Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice.

Authors:  P R Flatt; C J Bailey
Journal:  Horm Metab Res       Date:  1981-10       Impact factor: 2.936

3.  Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice.

Authors:  P R Flatt; C J Bailey; P Kwasowski; T Page; V Marks
Journal:  J Endocrinol       Date:  1984-06       Impact factor: 4.286

4.  beta-Endorphin in the human pancreas.

Authors:  J F Bruni; W B Watkins; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

5.  Morphine hyperglycaemia.

Authors:  W Feldberg; K P Gupta
Journal:  J Physiol       Date:  1974-05       Impact factor: 5.182

6.  Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoractive nerves.

Authors:  L I Larsson
Journal:  J Histochem Cytochem       Date:  1979-09       Impact factor: 2.479

7.  beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).

Authors:  D L Margules; B Moisset; M J Lewis; H Shibuya; C B Pert
Journal:  Science       Date:  1978-12-01       Impact factor: 47.728

8.  Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice.

Authors:  P R Flatt; C J Bailey; P Kwasowski; S K Swanston-Flatt; V Marks
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

9.  Effect of enkephalins and morphine on insulin secretion from isolated rat islets.

Authors:  I C Green; D Perrin; K C Pedley; R D Leslie; D A Pyke
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

10.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

Authors:  B K Handa; A C Land; J A Lord; B A Morgan; M J Rance; C F Smith
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more
  6 in total

1.  Mice lacking δ-opioid receptors resist the development of diet-induced obesity.

Authors:  Traci A Czyzyk; Amparo Romero-Picó; John Pintar; Jaime H McKinzie; Matthias H Tschöp; Michael A Statnick; Ruben Nogueiras
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

2.  Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.

Authors:  B Ahrén
Journal:  Int J Pancreatol       Date:  1989-09

3.  Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies.

Authors:  A M Delaigle; M Senou; Y Guiot; M-C Many; S M Brichard
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

4.  Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully 'switchable' in vivo mouse model of diabetes.

Authors:  S Zervou; Y-F Wang; A Laiho; A Gyenesei; L Kytömäki; R Hermann; S Abouna; D Epstein; S Pelengaris; M Khan
Journal:  Diabetologia       Date:  2010-09-16       Impact factor: 10.122

5.  Activation of nucleus accumbens μ-opioid receptors enhances the response to a glycaemic challenge.

Authors:  Laura L Koekkoek; Tess Kool; Leslie Eggels; Luna L van der Gun; Khalid Lamuadni; Margo Slomp; Charlene Diepenbroek; Mireillle J Serlie; Andries Kalsbeek; Susanne E la Fleur
Journal:  J Neuroendocrinol       Date:  2021-08-26       Impact factor: 3.870

Review 6.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.